ZAPI aims to shorten the time to adequately respond to emerging infectious diseases using a One Health approach (http://zapi-imi.eu). The project will yield platforms for the rapid identification and production of viral domains that can be used as veterinary vaccines and will yield platforms for the rapid development, selection and production of protective antibodies to protect the human population. The project will not only aim at rapid development of these products, but also ensure fast track registration and implementation of the control tools as soon as possible after pathogen emergence. Artemis Bio-Support is involved in developing tests for evaluation of vaccine immunogenicity: avidity, neutralizing titers, glycosylation profile, and ADCC. In addition, Artemis Bio-Support is engaged in development of a new technique for epitope mapping of monoclonal antibodies and nanobodies.